BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd

A Maryland federal judge on Thursday granted final approval to a $15 million settlement to close out a stockholder derivative suit claiming Emergent BioSolutions Inc. and its top brass made a...

Already a subscriber? Click here to view full article